| Cardiovascular Risk Management |
1 |
1 |
| Toxicology |
0 |
0.99 |
| Hypertension |
0 |
0.84 |
| Coronary Artery Disease (CAD) |
0 |
0.81 |
| Cardiometabolic Risk Factors |
0 |
0.66 |
| Arsenic |
0 |
0.98 |
| Heart Failure (HF) |
0 |
0.6 |
| Heart |
0 |
0.53 |
| Cardiomyopathy |
0 |
0.41 |
| Pollutant |
0 |
0.35 |
| Cardiovascular disease |
0 |
0.26 |
| Lipids Management |
0 |
0.23 |
| Atherosclerosis |
0 |
0.21 |
| Peripheral Artery Disease |
0 |
0.21 |
| Artery |
0 |
0.17 |
| Cerebrovascular Accident |
0 |
0.15 |
| Healthcare and Medical Technology |
0 |
0.13 |
| Oxidative Stress |
0 |
0.12 |
| Revenue and Practice Management |
0 |
0.12 |
| Antihypertensive Agents |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Dyslipidemia |
0 |
0.09 |
| Environmental Medicine |
0 |
0.09 |
| Epidemiology |
0 |
0.09 |
| Epigenetics |
0 |
0.09 |
| Exercise |
0 |
0.09 |
| Kidney |
0 |
0.09 |
| Left Ventricular Hypertrophy (LVH) |
0 |
0.09 |
| New York |
0 |
0.09 |
| Salary and Compensation |
0 |
0.09 |
| Statins |
0 |
0.09 |
| Stenosis |
0 |
0.09 |
| Stress |
0 |
0.09 |
| Tobacco Use |
0 |
0.09 |
| Weight Loss |
0 |
0.09 |
| Genomic Medicine |
0 |
0.08 |
| Tobacco Cessation |
0 |
0.08 |
| Weight Management |
0 |
0.08 |